C O V E R S T O R Y
Single gene tests - MiSeq
Small gene panels
The Remarkable Journey
2 13
Series A funding of $ 4m led by Emerge Ventures
Exome sequencing – all genes Gene Panels HiSeq
2 14
NIPT – Non Invasive Prenatal testing
HLA matching – for transplants
2 15
Series B funding of $ 20m led by Sequoia
Genome Asia 100k PGS – for IVF
2 16
Carrier screening test Liquid biopsy
CAP accreditation , Bangalore lab
2 17
Series C1funding $ 40m led by Sequoia India and Sofina , Zodius Capital & HDFC
Comprehensive ( SNVs , CNVs & fusions )
Solid & liquid tumor panels
Coronary Artery Disease ( Polygenic risk score )
Infectious diseases portfolio including TB
Comprehensive TB Portfolio ( Routine and Molecular )
ICMR approved Lab for Covid Testing
2 18
2 19
2 13 2 2
$ 55m Series C2 funding led by Leapfrog
Launched Personal Genomics Division - Genessense
Additional Cancer Tests
Source : MedGenome
2 21
2 13 22
Series C3 funding of $ 16.5m led by IFC World Bank Group
Series D funding of $ 50m led by Novo Holdings , a leading international life sciences investor
24
BioVoiceNews | March / April 2024